Wake Forest University Baptist Medical Center Selects QuadraMed Enterprise Scheduling to Increase Operational Efficiencies

QuadraMed® Corporation (NASDAQ:QDHC), a leading provider of healthcare information technologies and services that help turn quality care into positive financial outcomes, today announced that Wake Forest University Baptist Medical Center has selected QuadraMed’s Enterprise Scheduling™ (QES) solution to schedule hospital ancillary procedures and accelerate reimbursements. Named as one of “America’s Best Hospitals” in five categories by U.S. News & World Report in 2009, Wake Forest Baptist will implement QuadraMed’s enterprise scheduling solution to automate workflow for improved clinician and patient satisfaction, as well as increased organizational productivity.

The rules-based QES system enables healthcare organizations to centralize and streamline their patient access processes. QES features QuadraMed’s advanced identity management technology to ensure accurate patient identification at the earliest opportunity to avoid downstream errors and rework. Additionally, the solution provides automated call-back reminders for patient visits and upfront medical-necessity verification to accelerate reimbursements.

“QuadraMed’s scheduling solution will help us centralize ancillary procedure scheduling functions and optimize our staff utilization for better delivery of patient care,” said Joe Foster, associate director of information services at Wake Forest Baptist. “Radiology will be the first major ancillary implemented, with other ancillary departments to follow in a phased roll-out. Our previous experience implementing QuadraMed solutions with our existing applications was very positive, so we were confident that QES would easily integrate with our existing ambulatory and acute care systems.”

Wake Forest Baptist’s integrated health system includes North Carolina Baptist Hospital and Wake Forest University Health Sciences, which consists of the Wake Forest University School of Medicine and Wake Forest University Physicians. With 22 affiliate hospitals, the award-winning healthcare organization is responsible for more than 1,000 acute care, rehabilitation, long-term, and psychiatric care beds, as well as outpatient services, and community health and information centers.

“QES provides health care organizations with the tools to simplify patient access and scheduling, which then minimizes scheduling conflicts and expensive delays,” said Duncan W. James, QuadraMed's president and CEO. “With the continued pressure on healthcare reimbursement practices, it’s even more important to immediately capture critical patient registration and billing information to ensure appropriate and timely payment for patient visits and procedures.”

About QuadraMed Corporation

QuadraMed® – (NASDAQ:QDHC) is a leading provider of healthcare technologies and services that help turn quality care into positive financial outcomes. QuadraMed provides innovative solutions that streamline processes, ensure compliance and help healthcare professionals deliver quality patient care. Behind the Company's products and services is a staff of 600 professionals whose experience and dedication have earned QuadraMed the trust and loyalty of clients at over 2,000 healthcare provider facilities. For more information about QuadraMed, visit http://www.quadramed.com.

Cautionary Statement on Risks Associated with QuadraMed Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. The words “believe,” “expect,” “target,” “goal,” “project,” “anticipate,” “predict,” “intend,” “plan,” “estimate,” “may,” “will,” “should,” “could” and similar expressions and their negatives are intended to identify such statements. Forward-looking statements are not guarantees of future performance, anticipated trends or growth in businesses, or other characterizations of future events or circumstances and are to be interpreted only as of the date on which they are made. QuadraMed undertakes no obligation to update or revise any forward-looking statement. You should not place undue reliance on these forward-looking statements. Our actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including the risks faced by QuadraMed described in documents filed with the Securities and Exchange Commission ("SEC") from time to time. QuadraMed’s SEC filings can be accessed through the Investor Relations section of our website, www.quadramed.com, or through the SEC’s EDGAR Database at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833).

QuadraMed is a registered trademark of QuadraMed Corporation. All other trademarks are the property of their respective holders.